A framework for mid-year research protocol review — how to assess what's working in your peptide and supplement stack, what biomarkers to check at 6 months, which compounds to cycle off for H2, what new research to incorporate, and how to design an optimized second-half protocol.

A research roundup covering major themes in peptide and longevity science for Q2 2026 — GLP-1 receptor agonist expansion, GH peptide research, senolytic compounds, NAD+ clinical data, AI-assisted peptide design, and the evolving regulatory landscape for research peptides.

Research overview of microdosing principles as applied to peptides, adaptogens, and other bioactives — the concept of sub-threshold dosing for receptor sensitivity maintenance, hormesis in GH peptides, and how low-dose cycling differs from standard dosing research in terms of receptor dynamics.

Research overview of CJC-1295 with Drug Affinity Complex (DAC) — how the DAC albumin-binding technology extends half-life from 30 minutes to 6-8 days, bleed GH vs pulsatile comparison, typical research doses (1-2mg weekly), and comparison with MOD GRF 1-29 (CJC-1295 without DAC).

A research-focused guide to telomere biology, telomerase activators (Epitalon, TA-65/cycloastragenol), lifestyle interventions, telomere measurement methods, and Epitalon dosing protocols.

A comprehensive research overview of PEG-MGF and MGF: mechanism of action, satellite cell activation, dosing protocols, reconstitution, and comparison with IGF-1 LR3.